Estimation of prevalence of red cell alloantibodies in patients with Beta Thalassaemia Major in Sri Lanka.

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL

Ceylon Medical Journal Pub Date : 2021-12-20 DOI:10.4038/cmj.v66i2.9472

S. Senavirathna, Lakmali Ranasinghe, Yashobha Thilakarathne

引用次数: 0

Abstract

Background and objectives: Major beta thalassaemia is an inherited haemolytic disease that needs regular blood transfusion as a standard treatment. Blood transfusion is generally safe; however, adverse effects can occur and one of which is red cell alloimmunization that can lead to acute or delayed haemolytic transfusion reactions. This study was designed to estimate the prevalence of red cell alloantibodies in patients with thalassaemia in Sri Lanka.

查看原文本刊更多论文

斯里兰卡主要β地中海贫血患者红细胞同种抗体患病率的评估。

背景和目的:重度地中海贫血是一种遗传性溶血性疾病，需要定期输血作为标准治疗。输血通常是安全的;然而，可能发生不良反应，其中之一是红细胞异体免疫，可导致急性或延迟溶血性输血反应。本研究旨在估计斯里兰卡地中海贫血患者中红细胞同种异体抗体的患病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ceylon Medical Journal MEDICINE, GENERAL & INTERNAL-

自引率

0.00%

发文量

期刊介绍： The Ceylon Medical Journal, is the oldest surviving medical journal in Australasia. It is the only medical journal in Sri Lanka that is listed in the Index Medicus. The CMJ started life way back in 1887 as the organ of the Ceylon Branch of the British Medical Association. Except for a brief period between 1893 and 1904 when it ceased publication, the CMJ or its forbear, the Journal of the Ceylon Branch of the British Medical Association, has been published without interruption up to now. The journal"s name changed to the CMJ in 1954.